T cell therapy combines immunology and genetic engineering to create potent anti cancer treatments. By enhancing the body’s own cellular defenses, it provides targeted and adaptive responses against malignancies. Expanding research pipelines continue to unlock broader therapeutic possibilities. Market Overview The T cell therapy market was valued at US$ 2,754.0 million in 2022 and is...

T cell therapy involves collecting T cells from a patient, genetically engineering them to improve tumor recognition, and reinfusing them into the body. This personalized process strengthens the immune response against malignant cells. It represents a major advancement in precision oncology and individualized medicine. Market Overview The T cell therapy market was valued at US$ 2,754.0 million...